{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:30:20Z","timestamp":1794547820689,"version":"4.9.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Suzhou Science and Technology Development Program","award":["SS202075"],"award-info":[{"award-number":["SS202075"]}]},{"name":"Suzhou Science and Technology Development Program","award":["SS202075"],"award-info":[{"award-number":["SS202075"]}]},{"name":"Suzhou Science and Technology Development Program","award":["SS202075"],"award-info":[{"award-number":["SS202075"]}]},{"name":"Suzhou Science and Technology Development Program","award":["SS202075"],"award-info":[{"award-number":["SS202075"]}]},{"name":"Suzhou Science and Technology Development Program","award":["SS202075"],"award-info":[{"award-number":["SS202075"]}]},{"name":"Suzhou Science and Technology Development Program","award":["SS202075"],"award-info":[{"award-number":["SS202075"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To establish the population pharmacokinetics (PPK) of magnesium sulfate (MgSO<jats:sub>4<\/jats:sub>)in women with preeclampsia (PE), and to determine the key covariates having an effect in magnesium pharmacokinetics in Chinese PE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Pregnant women with PE prescribed MgSO4 were enrolled in this prospective study from April 2021 to April 2023. On the initial day of administration, the patients were administered a loading dose of 5\u00a0g in conjunction with 10\u00a0g of magnesium sulfate as a maintenance dose. On the second day, only the maintenance dose was administration, and maternal blood samples were taken at 0, 4, 5, and 12\u00a0h after the second day\u2019s 10\u00a0g maintenance dose. The software Phoenix was used to estimate PPK parameters of MgSO4, such as clearance (CL) and volume of distribution (V), and to model PPK models with patient demographic, clinical, and laboratory covariates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 199 blood samples were collected from 51 women with PE and PPK profiles were analyzed. The PPK of MgSO<jats:sub>4<\/jats:sub> is consistent with to a one-compartment model. The base model adequately described the maternal serum magnesium concentrations after magnesium administration. The population parameter estimates were as follows: CL was 2.98\u00a0L\/h, V was 25.07\u00a0L. The model predictions changed significantly with covariates (BMI, creatinine clearance, and furosemide). Furosemide statistically influences V. The creatinine clearance, BMI and furosemide jointly affects CL. Monte Carlo simulation results showed that a loading dose combined with a maintenance dose would need to be administered daily to achieve the therapeutic blood magnesium concentrations. For the non-furosemide group, the optimal dosing regimen was a 5\u00a0g loading dose combined with a 10\u00a0g maintenance dose of MgSO4. For the furosemide group, the optimal dosing regimen was a 2.5\u00a0g loading dose combined with a 10\u00a0g maintenance dose of MgSO4.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The magnesium PPK model was successfully developed and evaluated in Chinese preeclampsia population, and the dose optimization of MgSO<jats:sub>4<\/jats:sub> was completed through Monte Carlo simulation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-024-06620-x","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T11:09:08Z","timestamp":1718276948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Population pharmacokinetics and dose optimization of magnesium sulfate in Chinese preeclampsia population"],"prefix":"10.1186","volume":"24","author":[{"given":"Jing","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"issue":"1","key":"6620_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.semperi.2011.09.011","volume":"36","author":"L Ghulmiyyah","year":"2012","unstructured":"Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia\/eclampsia. Semin Perinatol. 2012;36(1):56\u20139.","journal-title":"Semin Perinatol"},{"issue":"10297","key":"6620_CR2","first-page":"341","volume":"398","author":"LC Chappell","year":"2021","unstructured":"Chappell LC, et al. Pre-eclampsia Lancet. 2021;398(10297):341\u201354.","journal-title":"Pre-eclampsia Lancet"},{"issue":"8","key":"6620_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11906-017-0757-7","volume":"19","author":"LM Amaral","year":"2017","unstructured":"Amaral LM, et al. Pathophysiology and current clinical management of Preeclampsia. Curr Hypertens Rep. 2017;19(8):61.","journal-title":"Curr Hypertens Rep"},{"issue":"9321","key":"6620_CR4","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","volume":"359","author":"D Altman","year":"2002","unstructured":"Altman D, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359(9321):1877\u201390.","journal-title":"Lancet"},{"issue":"12","key":"6620_CR5","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/1471-0528.14400","volume":"124","author":"Q Long","year":"2017","unstructured":"Long Q, et al. Clinical practice patterns on the use of magnesium sulphate for treatment of pre-eclampsia and eclampsia: a multi-country survey. BJOG. 2017;124(12):1883\u201390.","journal-title":"BJOG"},{"key":"6620_CR6","doi-asserted-by":"crossref","unstructured":"ACOG Practice Bulletin 202: gestational hypertension and Preeclampsia. Obstet Gynecol, 2019. 133(1): p. 1.","DOI":"10.1097\/AOG.0000000000003020"},{"issue":"3","key":"6620_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/1471-0528.13753","volume":"123","author":"BO Okusanya","year":"2016","unstructured":"Okusanya BO, et al. Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia. BJOG. 2016;123(3):356\u201366.","journal-title":"BJOG"},{"issue":"1","key":"6620_CR8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1186\/s12884-020-03277-0","volume":"20","author":"J Li","year":"2020","unstructured":"Li J, et al. Risk factors for sub-therapeutic serum concentrations of magnesium sulfate in severe preeclampsia of Chinese patients. BMC Pregnancy Childbirth. 2020;20(1):578.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"6620_CR9","first-page":"227","volume":"55","author":"Subgroup","year":"2020","unstructured":"Hypertensive Disorders in Pregnancy, Subgroup, C.S.o.O. and, Gynecology CMA. [Diagnosis and treatment of hypertension and pre-eclampsia in pregnancy: a clinical practice guideline in China(2020)]. Zhonghua Fu Chan Ke Za Zhi. 2020;55(4):227\u201338.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"5","key":"6620_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3109\/14767050903156684","volume":"23","author":"K Guzin","year":"2010","unstructured":"Guzin K, et al. The effect of magnesium sulfate treatment on blood biochemistry and bleeding time in patients with severe preeclampsia. J Maternal-Fetal Neonatal Med. 2010;23(5):399\u2013402.","journal-title":"J Maternal-Fetal Neonatal Med"},{"issue":"6","key":"6620_CR11","doi-asserted-by":"publisher","first-page":"pe7371","DOI":"10.1016\/j.ajog.2015.12.060","volume":"214","author":"KF Brookfield","year":"2016","unstructured":"Brookfield KF, et al. Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women. Am J Obstet Gynecol. 2016;214(6):pe7371\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"6620_CR12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/jcph.1328","volume":"59","author":"L Du","year":"2019","unstructured":"Du L, et al. Population Pharmacokinetic modeling to Evaluate Standard Magnesium Sulfate treatments and Alternative Dosing regimens for Women with Preeclampsia. J Clin Pharmacol. 2019;59(3):374\u201385.","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"6620_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1067\/mob.2001.116726","volume":"185","author":"FS Chuan","year":"2001","unstructured":"Chuan FS, et al. Population pharmacokinetics of magnesium in preeclampsia. Am J Obstet Gynecol. 2001;185(3):593\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"6620_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s40268-020-00315-2","volume":"20","author":"TX da Costa","year":"2020","unstructured":"da Costa TX, et al. Population Pharmacokinetics of Magnesium Sulfate in Preeclampsia and Associated factors. Drugs R D. 2020;20(3):257\u201366.","journal-title":"Drugs R D"},{"issue":"1","key":"6620_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12884-018-1919-6","volume":"18","author":"T Easterling","year":"2018","unstructured":"Easterling T, et al. A randomized trial comparing the pharmacology of magnesium sulfate when used to treat severe preeclampsia with serial intravenous boluses versus a continuous intravenous infusion. BMC Pregnancy Childbirth. 2018;18(1):290.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"7","key":"6620_CR16","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/1471-0528.12222","volume":"120","author":"DH Salinger","year":"2013","unstructured":"Salinger DH, et al. Magnesium sulphate for prevention of eclampsia: are intramuscular and intravenous regimens equivalent? A population pharmacokinetic study. BJOG. 2013;120(7):894\u2013900.","journal-title":"BJOG"},{"issue":"13","key":"6620_CR17","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.2165\/00003088-200241130-00007","volume":"41","author":"J Lu","year":"2002","unstructured":"Lu J, et al. Pharmacokinetic-pharmacodynamic modelling of magnesium plasma concentration and blood pressure in preeclamptic women. Clin Pharmacokinet. 2002;41(13):1105\u201313.","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"6620_CR18","doi-asserted-by":"publisher","first-page":"100018","DOI":"10.1016\/j.xagr.2021.100018","volume":"1","author":"K Brookfield","year":"2021","unstructured":"Brookfield K, et al. Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsia. AJOG Glob Rep. 2021;1(4):100018.","journal-title":"AJOG Glob Rep"},{"key":"6620_CR19","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.2741\/2244","volume":"12","author":"A Jeyabalan","year":"2007","unstructured":"Jeyabalan A, Conrad KP. Renal function during normal pregnancy and preeclampsia. Front Biosci. 2007;12:2425\u201337.","journal-title":"Front Biosci"},{"issue":"6","key":"6620_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ajog.2023.07.021","volume":"229","author":"K Cagino","year":"2023","unstructured":"Cagino K, Prabhu M, Sibai B. Is magnesium sulfate therapy warranted in all cases of late postpartum severe hypertension? A suggested approach to a clinical conundrum. Am J Obstet Gynecol. 2023;229(6):641\u20136.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"6620_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1053\/j.ajkd.2021.09.029","volume":"80","author":"JE Novak","year":"2022","unstructured":"Novak JE, Ellison DH. Diuretics in States of volume overload: Core Curriculum 2022. Am J Kidney Dis. 2022;80(2):264\u201376.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"6620_CR22","doi-asserted-by":"publisher","first-page":"F958","DOI":"10.1152\/ajprenal.00476.2015","volume":"310","author":"X Huang","year":"2016","unstructured":"Huang X, et al. Everything we always wanted to know about furosemide but were afraid to ask. Am J Physiol Ren Physiol. 2016;310(10):F958\u201371.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"6","key":"6620_CR23","doi-asserted-by":"publisher","first-page":"F998","DOI":"10.1152\/ajprenal.00032.2017","volume":"312","author":"RT Alexander","year":"2017","unstructured":"Alexander RT, Dimke H. Effect of diuretics on renal tubular transport of calcium and magnesium. Am J Physiology-Renal Physiol. 2017;312(6):F998\u20131015.","journal-title":"Am J Physiology-Renal Physiol"},{"issue":"2","key":"6620_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/030006059001800207","volume":"18","author":"WP Leary","year":"1990","unstructured":"Leary WP, et al. Renal excretory actions of furosemide, of hydrochlorothiazide and of the vasodilator flosequinan in healthy subjects. J Int Med Res. 1990;18(2):120\u201341.","journal-title":"J Int Med Res"},{"issue":"3","key":"6620_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1081\/PRG-120024029","volume":"22","author":"V Dayicioglu","year":"2003","unstructured":"Dayicioglu V, et al. The use of standard dose of magnesium sulphate in prophylaxis of eclamptic seizures: do body mass index alterations have any effect on success? Hypertens Pregnancy. 2003;22(3):257\u201365.","journal-title":"Hypertens Pregnancy"},{"issue":"4","key":"6620_CR26","doi-asserted-by":"publisher","first-page":"e3271","DOI":"10.1016\/j.ajog.2013.05.042","volume":"209","author":"C Macdonald-Wallis","year":"2013","unstructured":"Macdonald-Wallis C, et al. Gestational weight gain as a risk factor for hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2013;209(4):e3271\u201317.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"6620_CR27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ejogrb.2013.03.016","volume":"169","author":"K Tomsin","year":"2013","unstructured":"Tomsin K, et al. Characteristics of heart, arteries, and veins in low and high cardiac output preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2013;169(2):218\u201322.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"6620_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ejogrb.2022.05.033","volume":"274","author":"P Tamas","year":"2022","unstructured":"Tamas P, et al. Preeclampsia subtypes: clinical aspects regarding pathogenesis, signs, and management with special attention to diuretic administration. Eur J Obstet Gynecol Reprod Biol. 2022;274:175\u201381.","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-024-06620-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-024-06620-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-024-06620-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T11:12:06Z","timestamp":1718277126000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-024-06620-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6620"],"URL":"https:\/\/doi.org\/10.1186\/s12884-024-06620-x","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]},"assertion":[{"value":"9 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Suzhou Municipal Hospital (K-2020-054-K01). All procedures were performed according to the Declaration of Helsinki. All methods were carried out in accordance with relevant guidelines and regulations. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"424"}}